Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Nucleic Acid Therapeutics
|
December 14, 2022
Consensus Guidelines for the Design and <i>In Vitro</i> Preclinical Efficacy Testing N-of-1 Exon Skipping Antisense Oligonucleotides
Annemieke Aartsma-Rus, Alejandro Garanto, Willeke van Roon-Mom, et al.
Nature Reviews. Microbiology
|
June 6, 2019
CRISPR-Cas in mobile genetic elements: counter-defence and beyond
Guilhem Faure, Sergey A Shmakov, Winston X Yan, et al.
Nature Biotechnology
|
June 6, 2017
Engineered Cpf1 variants with altered PAM specificities
Linyi Gao, David B T Cox, Winston X Yan, et al.
The CRISPR Journal
|
March 31, 2025
Initial Characterization of 12 New Subtypes and Variants of Type V CRISPR Systems
Jesse Tordoff, Lauren E Alfonse, Kira S Makarova, et al.
Nature Communications
|
May 13, 2017
BLISS is a versatile and quantitative method for genome-wide profiling of DNA double-strand breaks
Winston X Yan, Reza Mirzazadeh, Silvano Garnerone, et al.
Science (New York, N.Y.)
|
December 8, 2018
Functionally diverse type V CRISPR-Cas systems
Winston X Yan, Pratyusha Hunnewell, Lauren E Alfonse, et al.
Nature
|
April 2, 2015
In vivo genome editing using Staphylococcus aureus Cas9
F Ann Ran, Le Cong, Winston X Yan, et al.
Science (New York, N.Y.)
|
January 2, 2016
In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
Christopher E Nelson, Chady H Hakim, David G Ousterout, et al.
Science (New York, N.Y.)
|
January 2, 2016
In vivo gene editing in dystrophic mouse muscle and muscle stem cells
Mohammadsharif Tabebordbar, Kexian Zhu, Jason K W Cheng, et al.
Molecular Cell
|
November 25, 2022
The miniature CRISPR-Cas12m effector binds DNA to block transcription
Wen Y Wu, Prarthana Mohanraju, Chunyu Liao, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Nucleic Acid Therapeutics
|
December 14, 2022
Consensus Guidelines for the Design and <i>In Vitro</i> Preclinical Efficacy Testing N-of-1 Exon Skipping Antisense Oligonucleotides
Annemieke Aartsma-Rus, Alejandro Garanto, Willeke van Roon-Mom, et al.
Nature Reviews. Microbiology
|
June 6, 2019
CRISPR-Cas in mobile genetic elements: counter-defence and beyond
Guilhem Faure, Sergey A Shmakov, Winston X Yan, et al.
Nature Biotechnology
|
June 6, 2017
Engineered Cpf1 variants with altered PAM specificities
Linyi Gao, David B T Cox, Winston X Yan, et al.
The CRISPR Journal
|
March 31, 2025
Initial Characterization of 12 New Subtypes and Variants of Type V CRISPR Systems
Jesse Tordoff, Lauren E Alfonse, Kira S Makarova, et al.
Nature Communications
|
May 13, 2017
BLISS is a versatile and quantitative method for genome-wide profiling of DNA double-strand breaks
Winston X Yan, Reza Mirzazadeh, Silvano Garnerone, et al.
Science (New York, N.Y.)
|
December 8, 2018
Functionally diverse type V CRISPR-Cas systems
Winston X Yan, Pratyusha Hunnewell, Lauren E Alfonse, et al.
Nature
|
April 2, 2015
In vivo genome editing using Staphylococcus aureus Cas9
F Ann Ran, Le Cong, Winston X Yan, et al.
Science (New York, N.Y.)
|
January 2, 2016
In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
Christopher E Nelson, Chady H Hakim, David G Ousterout, et al.
Science (New York, N.Y.)
|
January 2, 2016
In vivo gene editing in dystrophic mouse muscle and muscle stem cells
Mohammadsharif Tabebordbar, Kexian Zhu, Jason K W Cheng, et al.
Molecular Cell
|
November 25, 2022
The miniature CRISPR-Cas12m effector binds DNA to block transcription
Wen Y Wu, Prarthana Mohanraju, Chunyu Liao, et al.
Page
of 3